[Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant patient].
BACKGROUND
Cutaneous vasculitis is a known complication of hepatitis B vaccination with recombinant vaccine.


METHODS
A renal transplant recipient with the HLD-DR4 susceptibility antigen developed histologically proven cutaneous vasculitis with serum antibodies after vaccination with anti-hepatitis B recombinant vaccine. The skin manifestation, evolved favorably after discontinuation of the immunization and bed rest.


CONCLUSIONS
This case suggests that anti-hepatitis B vaccination with recombinant vaccine can produce cutaneous vasculitis in renal transplant recipients. The vaccination strategy in this population should be revisited.
Bui-Quang
D
D
Service de Néphrologie-Hémodialyse, Centre Hospitalier, Niort.
Thomas
E
E
Riols
M
M
Levillain
P
P
Picaud
D
D
Séchet
A
A
Baron
M
M
Vérove
C
C
D001323:Autoantibodies / Q000097:blood; D002196:Capillaries / Q000473:pathology; D005260:Female; D015804:HLA-DR4 Antigen / Q000235:genetics; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D007249:Inflammation; D016030:Kidney Transplantation; D008875:Middle Aged; D012867:Skin / Q000098:blood supply* / Q000473:pathology; D014614:Vaccines, Synthetic / Q000009:adverse effects*; D014657:Vasculitis / Q000209:etiology* / Q000276:immunology / Q000473:pathology
D001323:Autoantibodies; D015804:HLA-DR4 Antigen; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic
Vascularite cutanée après vaccination contre l'hépatite virale B par vaccin recombinant chez une transplantée rénale.